Our Story

 

NEW VETERINARY VACCINE TECHNOLOGY
IS CHANGING THE WHOLE INDUSTRY

 

Now in its 5th year the World Veterinary Vaccine Congress will continue to bring experts from the global animal health industry to discuss scientific, regulatory and commercial issues affecting the veterinary biologics sector. The three day event will feature workshops, presentations, roundtable discussions and panels on Funding & Investment for Animal Health, One Health, AMR, Veterinary Immunology, Vaccine Technology, Delivery, Manufacturing & Biotherapeutics for Companion Animal Diseases.


Co-located with the 20th World Vaccine Congress Europe & 4th Immuno Oncology Profiling Congress. Not limited to vaccines, the event bridges human and animal health, bringing together world class speakers from the veterinary biologics, human vaccine & immuno-oncology industry with both scientific and commercial interests. This holistic approach helps accelerate research & development and collaboration in key areas such as; Innovation, Zoonotic & Transboundary Diseases, Technology Platforms, Vaccines, Clinical Models, Adjuvants & Immunotherapy. With 175+ speakers, 600+ attendees and hundreds of companies in attendance, this is not an event to be missed.

 

NEW VACCINE TECHNOLOGY AND PLATFORMS

Focused on R&D innovations, this congress will update you of the progression made in veterinary vaccine R&D and vaccine development challenges when developing vaccines against viral, bacterial and parasitic diseases within a variety of animal species. From modified live virus vaccines, DNA vaccines, subunit marker vaccines to novel adjuvanted vaccines, this congress brings all innovation together in one place

 

BIOPROCESSING, DELIVERY AND MANUFACTURING

Optimize early formulation through to clinical manufacturing, by embracing new techniques and technologies

 

ONE HEALTH

It is imperative for synergy between human and animal health to combat emerging zoonotic & transboundary diseases. Improve knowledge sharing & collaboration with regards to technology, adjuvants & clinical models: What can the human health industry learn from vet & vice versa?

 

 

 

INFLUENZA AND RESPIRATORY

Find ways to improve development of universal influenza, RSV, MERS and TB vaccines

 

EMERGING AND RE-EMERGING DISEASES

Understand the opportunities for your business in reacting to global threats like Zika, Malaria, Dengue and Ebola

 

ANTIMICROBIAL RESISTANCE AND EMERGING DISEASES

Expect the unexpected, explore the opportunities and challenges associated with emerging infectious diseases including African swine fever, avian influenza and Rift Valley Fever. Find out how the industry is working together to find alternative routes (vaccines) to slow down the rise of antimicrobial resistance, dengue and Ebola

 

THE WORLD VETERINARY VACCINE CONGRESS EUROPE WILL:

Provide a marketplace where the world’s leading veterinary vaccine focused CROs, CMOs, Equipment, Platform Technology and device manufacturers can showcase their services and products to decision makers.

Provide delegates one stop progressive scientific and strategic solutions to the veterinary vaccine industry, through executive level commentary, case studies and real time analysis from key stakeholders to bring about faster, more cost-effective and more efficacious vaccines.

Create a valuable marketplace for pharma and biotech involved in veterinary vaccines to source and compare products and services that will help them.

Explore the latest methods for improving bioprocessing and manufacturing methodologies for current and future veterinary vaccines and look into new technologies for vaccine development, including nanotech, synthetic biology and new-generation adjuvants.

Offer delegates updates on the latest discovery-stage prophylactic and therapeutic vaccines and hear clinical phase I, II and III data from leading biotech’s and big pharma.

Showcase C-Level executives from all the key vaccine developers and thought leaders from pharma, biotech’s, academics and government, in a combined scientific and commercial environment where CRO’s, CMO’s, Equipment, Platform Technology and device manufacturers can do business.

 

FOR WORLD-CLASS SOLUTION PROVIDERS

The World Veterinary Vaccine Congress Europe offers outstanding opportunities for service and solution providers, from senior sponsorship to a range of exhibition booths. If you are looking to gain access to key vaccine decision makers then this is your best ROI in 2019.

 

 




Very good organization, interesting mix of talks, good balance between panels and parallel tracks


Head R&D, Marburg GSK Vaccines



 

 

Sign Up for Event Updates